跳至主要内容
临床试验/NCT02249715
NCT02249715Unknown不适用

Pilot Study for Development of a Monitoring Set-up and Algorithm Using Functional MRI (fMRI) and EEG for Prediction of Response to Repetitive Deep Transcranial Magnetic Stimulation (rDTMS) for Patients With Parkinson's Disease

Sheba Medical Center0 个研究点目标入组 20 人开始时间: 2014年11月最近更新:
适应症

试验速览

阶段
不适用
入组人数
20
主要终点
Unified Parkinson's Disease Rating Scale (UPDRS)

研究概览

简要总结

  • To characterize physiological biomarkers of positive response to rDTMS using EEG and functional MRI (fMRI) in patients with PD.
  • To develop a set-up and algorithm for neurophysiological monitoring for PD patients using EEG and fMRI in patients treated by rDTMS.
  • To integrate rDTMS stimulation with monitoring techniques with the ultimate goal of providing closed-loop feedback where monitoring informs the stimulation

详细描述

PD Patients aged 40 years or older, diagnosed as idiopathic PD according to the UK Brain Bank criteria will be treated by an established rDTMS protocol will be monitored before, during and after rDTMS using quantitative EEG and brain network analysis and fMRI while performing a series of cognitive and motor tasks.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
40 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Idiopathic PD patients aged 40-75 years;
  • Hoehn and Yahr stages II to IV
  • Patients on stable antiparkinsonian therapy for 1 month
  • Right hand dominance with right afflicted side.

排除标准

  • Participation in current clinical study or clinical study within 30 days prior to this study.
  • Subject has an atypical parkinsonian syndrome or secondary parkinsonism (e.g., due to drugs, metabolic neurogenetic disorders, encephalitis, cerebrovascular disease or other degenerative disease)
  • Patients with significant psychiatric symptoms or history.
  • Patients with psychotic symptoms or active depressive symptoms
  • Treatment with neuroleptics.
  • Beck depression inventory (BDI) score <14
  • Mini Mental status examination (MMSE) score <25
  • History of migraine or frequent or severe headaches.
  • Significant sensory deficits, e.g., deafness or blindness History of head injury or neurosurgical interventions.
  • Subjects who have concomitant epilepsy, a history of seizure/s, heat convulsions or history of epilepsy in first degree relative.
  • History of any metal in the head (outside the mouth).
  • The presence of cochlear implants
  • Known history of any metallic particles in the eye, implanted cardiac pacemaker, implanted neurostimulators, surgical clips (above the shoulder line) or any medical pumps.
  • Subjects with an unstable medical disorder.
  • Current drug abuse (including Cannabis) or alcoholism.
  • Pregnancy or not using a reliable method of birth control.
  • Patients with severe tremor or dyskinesia

结局指标

主要结局

Unified Parkinson's Disease Rating Scale (UPDRS)

时间窗: 3 month

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Sponsor

相似试验

Development of a Monitoring Set-up and Algorithm... | 临床试验